NYSE:HUM

Humana - HUM Stock Forecast, Price & News

$486.00

-1.74 (-0.36%)

(As of 08/10/2022 12:00 AM ET)

Add

Compare

Today's Range: $483.45
▼
$493.22
50-Day Range: $423.21
▼
$495.31
52-Week Range: $351.20
▼
$497.47

Volume: 373,142 shs
Average Volume: 1.07 million shs
Market Capitalization: $61.51 billion

P/E Ratio: 19.84
Dividend Yield: 0.65%
Price Target: $508.61

Humana MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.71 Rating Score
Upside/Downside: 5.1% Upside
$510.63 Price Target
Short Interest: Healthy
1.31% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -0.75
Upright™ Environmental Score
News Sentiment: 0.16
Based on 13 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 11.75%
From $24.85 to $27.77 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.68 out of 5 stars

Medical Sector

85th out of 1,108 stocks

Hospital & Medical Service Plans Industry

3rd out of 11 stocks

2.4

Analyst's Opinion

Consensus Rating
Humana has received a consensus rating of Buy. The company's average rating score is 2.71, and is based on 12 buy ratings, 5 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $510.63, Humana has a forecasted upside of 5.1% from its current price of $486.00.
Amount of Analyst Coverage
Humana has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
1.31% of the float of Humana has been sold short.
Short Interest Ratio / Days to Cover
Humana has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Humana has recently increased by 2.48%, indicating that investor sentiment is decreasing.

3.3

Dividend Strength

Dividend Yield
Humana has a dividend yield of 0.65%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Humana has been increasing its dividend for 12 years.
Dividend Coverage
The dividend payout ratio of Humana is 12.86%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Humana will have a dividend payout ratio of 11.34% next year. This indicates that Humana will be able to sustain or increase its dividend.

3.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Humana has received a 52.17% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Health insurance services for individuals", "Health insurance services for groups", and "Physical retail of pharmaceuticals at a pharmacy" products. See details.
Environmental Sustainability
The Environmental Impact score for Humana is -0.75.

2.9

News and Social Media Coverage

News Sentiment
Humana has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 13 news articles for Humana this week, compared to 11 articles on an average week.
Search Interest
24 people have searched for HUM on MarketBeat in the last 30 days. This is an increase of 60% compared to the previous 30 days.
MarketBeat Follows
28 people have added Humana to their MarketBeat watchlist in the last 30 days. This is an increase of 367% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Humana insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.39% of the stock of Humana is held by insiders.
Percentage Held by Institutions
94.93% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Humana are expected to grow by 11.75% in the coming year, from $24.85 to $27.77 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Humana is 19.84, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 138.44.
Price to Earnings Ratio vs. Sector
The P/E ratio of Humana is 19.84, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 121.05.
Price to Earnings Growth Ratio
Humana has a PEG Ratio of 1.45. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Humana has a P/B Ratio of 3.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Humana (NYSE:HUM) Stock

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Humana Stock Performance

HUM opened at $487.74 on Wednesday. The stock has a market cap of $61.73 billion, a PE ratio of 19.91, a P/E/G ratio of 1.45 and a beta of 0.77. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.73. Humana has a 1 year low of $351.20 and a 1 year high of $497.47. The stock's 50 day simple moving average is $466.41 and its 200-day simple moving average is $445.11.

Humana (NYSE:HUM - Get Rating) last released its quarterly earnings data on Wednesday, July 27th. The insurance provider reported $8.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.67 by $1.00. The business had revenue of $23.66 billion for the quarter, compared to analysts' expectations of $23.44 billion. Humana had a return on equity of 18.42% and a net margin of 3.52%. Humana's quarterly revenue was up 14.6% on a year-over-year basis. During the same period in the previous year, the business posted $6.89 earnings per share. Sell-side analysts forecast that Humana will post 24.85 EPS for the current year.

Wall Street Analysts Forecast Growth

HUM has been the subject of several research reports. Cowen lifted their price target on Humana to $547.00 in a report on Tuesday. Credit Suisse Group set a $548.00 target price on Humana in a report on Tuesday, July 19th. StockNews.com lowered Humana from a "strong-buy" rating to a "buy" rating in a report on Friday, July 29th. Wells Fargo & Company boosted their target price on Humana from $512.00 to $514.00 and gave the stock an "overweight" rating in a report on Wednesday, May 25th. Finally, Sanford C. Bernstein started coverage on Humana in a report on Thursday, May 26th. They issued a "market perform" rating and a $506.00 target price for the company. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, Humana has a consensus rating of "Moderate Buy" and a consensus price target of $510.63.

Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

HUM Stock News Headlines

August 6, 2022 | nasdaq.com

3 Great Stocks to Buy in August for Safety and Long-Term Growth - Nasdaq

August 5, 2022 | americanbankingnews.com

Humana (NYSE:HUM) PT Raised to $494.00 at Morgan Stanley

August 4, 2022 | bizjournals.com

Your next dental visit could be right down the hallway from your office - Atlanta Business Chronicle - The Business Journals

August 3, 2022 | americanbankingnews.com

Q4 2022 EPS Estimates for Humana Inc. (NYSE:HUM) Cut by Analyst

August 3, 2022 | americanbankingnews.com

Q4 2022 EPS Estimates for Humana Inc. Reduced by Analyst (NYSE:HUM)

August 2, 2022 | businesswire.com

Humana Foundation Donates $500000 to Support Recovery in Wake of Devastating Flooding - Business Wire

August 2, 2022 | finance.yahoo.com

Humana Foundation Donates $500,000 to Support Recovery in Wake of Devastating Flooding

August 2, 2022 | finance.yahoo.com

Zacks Investment Ideas feature highlights: Humana and Centene

August 1, 2022 | benzinga.com

Here's How Much You Would Have Made Owning Humana Stock In The Last 15 Years - Benzinga

August 1, 2022 | americanbankingnews.com

Humana (NYSE:HUM) PT Raised to $540.00 at SVB Leerink

August 1, 2022 | americanbankingnews.com

Humana (NYSE:HUM) Price Target Raised to $529.00

August 1, 2022 | americanbankingnews.com

Oppenheimer Increases Humana (NYSE:HUM) Price Target to $520.00

July 31, 2022 | americanbankingnews.com

Q3 2022 EPS Estimates for Humana Inc. Boosted by Analyst (NYSE:HUM)

July 30, 2022 | americanbankingnews.com

Deutsche Bank Aktiengesellschaft Increases Humana (NYSE:HUM) Price Target to $514.00

July 29, 2022 | finance.yahoo.com

Here's Why Humana (NYSE:HUM) Has Caught The Eye Of Investors

July 29, 2022 | nasdaq.com

Are Investors Undervaluing Humana (HUM) Right Now? - Nasdaq

July 29, 2022 | finance.yahoo.com

Are Investors Undervaluing Humana (HUM) Right Now?

July 28, 2022 | nasdaq.com

Humana Boosts FY22 Adj. EPS Outlook - Update

July 28, 2022 | msn.com

Health insurer Humana's profit rises 52%

July 28, 2022 | reuters.com

Humana's cautious outlook fails to impress investors

July 28, 2022 | businessinsider.com

Trudy Busch Valentine says she'll 'stand up' to insurers. She also invests in them. - Business Insider

July 28, 2022 | investing.com

Humana Tops Q2 EPS by $1.01; Raises Outlook By Investing.com - Investing.com

July 27, 2022 | benzinga.com

Recap: Humana Q2 Earnings - Benzinga - Benzinga

July 27, 2022 | seekingalpha.com

Humana down 3% despite raising 2022 EPS guidance and Q2 top and bottom line beats (HUM) - Seeking Alpha

July 27, 2022 | forbes.com

Humana Reaps $696 Million Profit On Medicare Growth And Lower Costs - Forbes

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

HUM Company Calendar

Ex-Dividend for 7/29 Dividend: 6/29/2022
Last Earnings: 7/27/2022
Dividend Payable: 7/29/2022
Today: 8/10/2022
Next Earnings (Estimated): 11/02/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Hospital & medical service plans
Sub-Industry: Managed Health Care
Sector: Medical
Current Symbol: NYSE:HUM
CUSIP: 44485910
CIK: 49071
Web: www.humana.com
Phone: (502) 580-1000
Fax: 502-580-3639
Employees: 95,500
Year Founded: 1961

Price Target and Rating

Average Stock Price Forecast: $510.63
High Stock Price Forecast: $550.00
Low Stock Price Forecast: $415.00
Forecasted Upside/Downside: +4.7%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.71
Research Coverage: 17 Analysts

Profitability

EPS (Most Recent Fiscal Year): $24.50
Trailing P/E Ratio: 19.84
Forward P/E Ratio: 19.56
P/E Growth: 1.45
Net Income: $2.93 billion
Net Margins: 3.52%
Pretax Margin: 4.38%
Return on Equity: 18.42%
Return on Assets: 6.37%

Debt

Debt-to-Equity Ratio: 0.73
Current Ratio: 1.53
Quick Ratio: 1.53

Sales & Book Value

Annual Sales: $83.06 billion
Price / Sales: 0.74
Cash Flow: $26.43 per share
Price / Cash Flow: 18.39
Book Value: $125.28 per share
Price / Book: 3.88

Miscellaneous

Outstanding Shares: 126,554,000
Free Float: 126,060,000
Market Cap: $61.51 billion
Optionable: Optionable
Beta: 0.77

Social Links

Key Executives

Mr. Bruce Dale Broussard (Age 60)
Pres, CEO & Director
Comp: $3.92M
Ms. Susan Marie Diamond (Age 48)
Chief Financial Officer
Comp: $1.39M
Mr. Timothy S. Huval (Age 56)
Chief Admin. Officer
Comp: $1.43M
Mr. T. Alan Wheatley (Age 54)
Segment Pres of Retail
Comp: $1.41M
Dr. William Kevin Fleming Pharm.D. (Age 54)
PharmD, RPh, Chief Corp. Affairs Officer & Segment Pres of Pharmacy Solutions
Comp: $1.22M
Mr. Michael A. Koeberlein (Age 53)
Sr. VP, Chief Accounting Officer & Controller
Mr. Sam M. Deshpande (Age 57)
Chief Information Officer
Lisa M. Stoner
VP of Investor Relations
Mr. Joseph C. Ventura (Age 45)
Chief Legal Officer
Amy Fry
Sr. VP of Corp. Communications

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HUM Stock - Frequently Asked Questions

Should I buy or sell Humana stock right now?: 17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 5 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HUM shares.
View HUM analyst ratings or view top-rated stocks.
What is Humana's stock price forecast for 2022?: 17 Wall Street analysts have issued 1 year price targets for Humana's stock. Their HUM share price forecasts range from $415.00 to $550.00. On average, they predict the company's stock price to reach $510.63 in the next twelve months. This suggests a possible upside of 5.1% from the stock's current price.
View analysts price targets for HUM or view top-rated stocks among Wall Street analysts.
How have HUM shares performed in 2022?: Humana's stock was trading at $463.86 at the beginning of 2022. Since then, HUM stock has increased by 4.8% and is now trading at $486.00.
View the best growth stocks for 2022 here.
When is Humana's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our HUM earnings forecast.
How were Humana's earnings last quarter?: Humana Inc. (NYSE:HUM) released its quarterly earnings results on Wednesday, July, 27th. The insurance provider reported $8.67 earnings per share for the quarter, beating analysts' consensus estimates of $7.67 by $1.00. The insurance provider had revenue of $23.66 billion for the quarter, compared to the consensus estimate of $23.44 billion. Humana had a net margin of 3.52% and a trailing twelve-month return on equity of 18.42%. The company's quarterly revenue was up 14.6% on a year-over-year basis. During the same period in the prior year, the company posted $6.89 earnings per share.
Read the conference call transcript.
How often does Humana pay dividends? What is the dividend yield for Humana?: Humana declared a quarterly dividend on Thursday, April 21st. Investors of record on Thursday, June 30th will be paid a dividend of $0.7875 per share on Friday, July 29th. This represents a $3.15 annualized dividend and a dividend yield of 0.65%. The ex-dividend date is Wednesday, June 29th.
Read our dividend analysis for HUM.
Is Humana a good dividend stock?: Humana (NYSE:HUM) pays an annual dividend of $3.15 per share and currently has a dividend yield of 0.65%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 12.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 11.34% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HUM.
What guidance has Humana issued on next quarter's earnings?: Humana issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share guidance of $24.75-$24.75 for the period, compared to the consensus earnings per share estimate of $24.63. The company issued revenue guidance of -.

What is Bruce D. Broussard's approval rating as Humana's CEO?: 1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees.
What other stocks do shareholders of Humana own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).
What is Humana's stock symbol?: Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
Who are Humana's major shareholders?: Humana's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Lazard Asset Management LLC (0.79%), Allspring Global Investments Holdings LLC (0.67%), Swiss National Bank (0.43%), Sumitomo Mitsui Trust Holdings Inc. (0.38%), Jennison Associates LLC (0.32%) and Ceredex Value Advisors LLC (0.30%). Insiders that own company stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, David A Jr/Ky Jones, Elizabeth D Bierbower, James J /Ky Obrien, Jorge S Mesquita, Samir Deshpande, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends.
How do I buy shares of Humana?: Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Humana's stock price today?: One share of HUM stock can currently be purchased for approximately $486.00.
How much money does Humana make?: Humana (NYSE:HUM) has a market capitalization of $61.51 billion and generates $83.06 billion in revenue each year. The insurance provider earns $2.93 billion in net income (profit) each year or $24.50 on an earnings per share basis.
How many employees does Humana have?: The company employs 95,500 workers across the globe.
Does Humana have any subsidiaries?: The following companies are subsidiares of Humana: 154th Street Medical Plaza, 516-526 West Main Street Condominium Council of Co-Owners, 54th Street Medical Plaza, American Eldercare, American Eldercare of North Florida, Anvita Health, Arcadian Health Plan, Arcadian Management Services, Atlantis Physician Group, CAC Medical Center Holdings, CAC-Florida Medical Centers, CDO 1, CDO 2, CHA HMO, CHA Service Company, Care Partners Home Care, CareNetwork, CarePlus Health, CarePlus Health Plans, Cariten Health Plan Inc., Certify Data Systems, CompBenefits, CompBenefits Company, CompBenefits Corporation, CompBenefits Dental, CompBenefits Direct, CompBenefits Insurance Company, Complex Clinical Management, Concentra Managed Care, Continucare Corporation, Continucare MDHC, Continucare MSO, Continucare Medical Management, Dental Care Plus Management, DentiCare, Emphesys, Emphesys Insurance Company, Enclara Healthcare, FPG, FPG Acquisition Corp., FPG Acquisition Holdings Corp., FPG Senior Services, Family Physicians of Winter Park, Go365, HUM Provider Holdings, HUM-e-FL, Harris Rothenberg International, Health Value Management, Humana Active Outlook, Humana At Home (Dallas), Humana At Home (Houston), Humana At Home (San Antonio), Humana At Home (TLC), Humana At Home 1, Humana Behavioral Health, Humana Benefit Plan of Illinois, Humana Dental Company, Humana Digital Health and Analytics Platform Services, Humana EAP and Work-Life Services of California, Humana Employers Health Plan of Georgia, Humana Government Business, Humana Health Benefit Plan of Louisiana, Humana Health Company of New York, Humana Health Insurance Company of Florida, Humana Health Plan, Humana Health Plan of California, Humana Health Plan of Ohio, Humana Health Plan of Texas, Humana Health Plans of Puerto Rico, Humana Healthcare Research, Humana Inc., Humana Innovation Enterprises, Humana Insurance Company, Humana Insurance Company of Kentucky, Humana Insurance Company of New York, Humana Insurance of Puerto Rico, Humana Management Services of Puerto Rico, Humana MarketPOINT, Humana MarketPOINT of Puerto Rico, Humana Medical Plan, Humana Medical Plan of Michigan, Humana Medical Plan of Pennsylvania, Humana Medical Plan of Utah, Humana Pharmacy, Humana Pharmacy Solutions, Humana Regional Health Plan, Humana Veterans Healthcare Services, Humana WellWorks LLC, Humana Wisconsin Health Organization Insurance Corporation, Humana at Home, HumanaDental, HumanaDental Insurance Company, Humco, Hummingbird Coaching Systems LLC, Independent Care Health Plan, KMG America, Kindred Healthcare, MCCI Group Holdings, MCCI Holdings, MCCI Medical Group, MCCI Specialty, MCCI/Lifetime of Aventura, MD Care, METCARE of Florida, Managed Care Indemnity, Medical Care Consortium Incorporated of Texas, MetCare, Metropolitan Health Networks, Naples Health Care Specialists, North Region Providers, Nursing Solutions, OSF HealthCare, PHP Companies, Partners in Integrated Care, Preferred Health Partnership, Preservation on Main, Primary Care Holdings, Primary Care Holdings II, Primary Care Specialists of the Palm Beaches, RMA Medical Centers of Florida, RMA Medical Group of Florida, ROHC, SeniorBridge, SeniorBridge Family Companies (CT), SeniorBridge Family Companies (FL), SeniorBridge Family Companies (IN), SeniorBridge Family Companies (MO), SeniorBridge Family Companies (NY), SeniorBridge-Florida, Texas Dental Plans, The Dental Concern, Transcend Population Health Management, and Transcend Population Health Management II.
Read More
When was Humana founded?: Humana was founded in 1961.
How can I contact Humana?: Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The official website for the company is www.humana.com. The insurance provider can be reached via phone at (502) 580-1000, via email at amysmith@humana.com, or via fax at 502-580-3639.

This page (NYSE:HUM) was last updated on 8/11/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Humana - HUM Stock Forecast, Price & News

Humana MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Humana (NYSE:HUM) Stock

Humana Stock Performance

Wall Street Analysts Forecast Growth

HUM Stock News Headlines

HUM Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

HUM Stock - Frequently Asked Questions

Should I buy or sell Humana stock right now?

What is Humana's stock price forecast for 2022?

How have HUM shares performed in 2022?

When is Humana's next earnings date?

How were Humana's earnings last quarter?

How often does Humana pay dividends? What is the dividend yield for Humana?

Is Humana a good dividend stock?

What guidance has Humana issued on next quarter's earnings?

What is Bruce D. Broussard's approval rating as Humana's CEO?

What other stocks do shareholders of Humana own?

What is Humana's stock symbol?

Who are Humana's major shareholders?

How do I buy shares of Humana?

What is Humana's stock price today?

How much money does Humana make?

How many employees does Humana have?

Does Humana have any subsidiaries?

When was Humana founded?

How can I contact Humana?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™